Andrew Stober
Chief Manufacturing Officer @ Encoded Therapeutics
About Andrew Stober
Andrew Stober is a seasoned manufacturing executive in the biotechnology sector, currently serving as the Chief Manufacturing Officer, with extensive experience in gene therapy manufacturing and supply chain operations.
Known information
Andrew Stober is a prominent figure in the biotechnology manufacturing industry, holding the position of Chief Manufacturing Officer. He has a rich background in the field, having previously served as Senior Vice President and Chief Technical Officer at Novartis, where he was responsible for overseeing gene therapy manufacturing, program management, engineering, and supply chain operations. His significant contributions include supporting the evolution of corporate manufacturing capabilities for the gene therapy portfolio at AveXis, guiding it from clinical development through to product launch. Prior to his roles at Novartis and AveXis, Stober held multiple senior manufacturing positions at Biogen, ultimately serving as Senior Director of Manufacturing. His early career involved various capacities at well-known companies such as Amgen and Merck & Co. Stober’s educational foundation is a B.S. in Chemical Engineering from Lehigh University, equipping him with the technical expertise required for his advanced roles in the industry.
About Encoded Therapeutics
Encoded Therapeutics focuses on developing precision gene therapies for pediatric central nervous system disorders, with its leading program, ETX101, targeting Dravet syndrome.